ROC curve analysis was conducted to evaluate the diagnostic efficacy of CD302, revealing an area under the curve (AUC) of 0.912 (P < 0.001; 95% CI: 0.889–0.935), which underscores its high discriminative power in distinguishing tumor tissues from adjacent normal tissues (Figure 3G). This evidence concerns the gene CD302 and neoplasm.